- KR₩2tn
- KR₩2tn
- KR₩1tn
- 55
- 33
- 12
- 19
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.27 | ||
| Price to Tang. Book | 2.46 | ||
| Price to Free Cashflow | 56.37 | ||
| Price to Sales | 1.49 | ||
| EV to EBITDA | 29.81 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 15.35% | ||
| Return on Equity | 12.9% | ||
| Operating Margin | 10.45% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 816,618.82 | 857,383.42 | 950,164.82 | 1,046,054.21 | 1,247,906.38 | n/a | n/a | 12% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +31.2 | -26.45 | +112.91 | +22.13 | +73.06 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hanmi Science Co Ltd is a Korean-based holding company principally involved in the management of subsidiaries. Through subsidiaries in Japan, Europe and Korea, the Company operates in three segments. The Pharmaceutical Products Wholesale segment mainly engages in the distribution of pharmaceutical products. The Holding Business segment mainly engages in the business of controlling subsidiaries. The Other segment mainly engage in the production and sales of pharmaceuticals, and the supply of quasi-drugs and health functional foods, beverages and functional cosmetics.
Directors
- Yeong Suk Song CHM (72)
- Jong Yun Yim CPR (48)
- Se Chang Gwon CPR (57)
- Jong Su Woo CPR (53)
- Jong Ho Yim MDR (59)
- Gi Ho Song OTH (49)
- Ui Yin Hwang NID (66)
- Yu Cheol Shin NID (56)
- Jae Oh Song NID (73)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- June 15th, 1973
- Public Since
- June 20th, 1988
- No. of Shareholders
- 38,496
- No. of Employees
- 98
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Korea Exchange - KSE- Shares in Issue
- 67,713,706
- Address
- Paltan Industrial Complex, HWASEONG, 18536
- Web
- https://hanmiscience.co.kr/
- Phone
- +82 24109114
- Auditors
- Deloitte Anjin LLC
Upcoming Events for 008930
Q1 2025 Hanmi Science Co Ltd Earnings Release
Similar to 008930
Aprogen Biologics
Korea Exchange - KSE
Boryung
Korea Exchange - KSE
Bukwang Pharm Co
Korea Exchange - KSE
Chong Kun Dang Pharmaceutical
Korea Exchange - KSE
CKD Bio
Korea Exchange - KSE
FAQ
What is the Hanmi Science Co share price?
As of Today at 20:01 UTC, shares in Hanmi Science Co are trading at KR₩28,200. This share price information is delayed by 15 minutes.
How has the Hanmi Science Co share price performed this year?
Shares in Hanmi Science Co last closed at KR₩28,200 and the price had moved by -23.78% over the past 365 days. In terms of relative price strength the Hanmi Science Co share price has underperformed the FTSE Developed Asia Pacific Index by -27.58% over the past year.
What are the analyst and broker recommendations for Hanmi Science Co?
There is no consensus recommendation for this security.
Find out moreWhat is the Hanmi Science Co dividend yield?
The Hanmi Science Co dividend yield is 1.06% based on the trailing twelve month period.
Does Hanmi Science Co pay a dividend?
Last year, Hanmi Science Co paid a total dividend of KR₩300, and it currently has a trailing dividend yield of 1.06%. We do not have any data on when Hanmi Science Co is to next pay dividends.
When does Hanmi Science Co next pay dividends?
We do not have data on when Hanmi Science Co is to next pay dividends. The historic dividend yield on Hanmi Science Co shares is currently 1.06%.
How do I buy Hanmi Science Co shares?
To buy shares in Hanmi Science Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hanmi Science Co?
As of the previous close price of KR₩28,200, shares in Hanmi Science Co had a market capitalisation of KR₩2tn.
Where are Hanmi Science Co shares listed?
Here are the trading details for Hanmi Science Co:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 008930
What kind of share is Hanmi Science Co?
Based on an overall assessment of its quality, value and momentum Hanmi Science Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hanmi Science Co share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Hanmi Science Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hanmi Science Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -8.38%.
As of the last closing price of KR₩28,200, shares in Hanmi Science Co were trading -18.16% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hanmi Science Co PE Ratio?
The Hanmi Science Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩28,200.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hanmi Science Co?
Hanmi Science Co's management team is headed by:
- Yeong Suk Song - CHM
- Jong Yun Yim - CPR
- Se Chang Gwon - CPR
- Jong Su Woo - CPR
- Jong Ho Yim - MDR
- Gi Ho Song - OTH
- Ui Yin Hwang - NID
- Yu Cheol Shin - NID
- Jae Oh Song - NID